Biotechnology lays the groundwork for the present and future of healthcare and drives the ... 07/04/2024 AseBio's health pipeline includes 130 molecules for 150 indications being researched by 40 national companies, with... AseBio
Celtarys Research, USC-biofarma and ZeClinics seek new therapeutic targets for Parkinson's... 01/04/2024 Healthcare Access to innovation Drug discovery Innovative drugs Advanced therapies This project, coordinated by Asebio, brings together ZeClinics' target validation and in vivo drug screening... AseBio
A consortium led by Hemostatics receives €2.5 M to validate a revolutionary therapy agains... 25/03/2024 Healthcare Advanced therapies A public-private consortium, led by the Spanish biotech company Hemostatics, located in the Barcelona Science Park, and... Partners - Parc Científic de Barcelona
Almirall signs licensing agreement with Eloxx Pharmaceuticals and enters the field of rare... 25/03/2024 Healthcare Access to innovation Rare diseases Personalized medicine Advanced therapies The Spanish pharmaceutical company has obtained global rights to develop and commercialize the drug ZKN-013. Partners - Almirall
The commercial corporation of advanced therapies, an opportunity to leverage Spanish devel... 14/03/2024 Healthcare Advanced therapies The Spanish biotech industry is present throughout the value chain of advanced therapy development and manufacturing... AseBio
The commercial corporation of advanced therapies, an opportunity to leverage Spanish devel... 14/03/2024 With the creation of this commercial corporation, it is expected to "bring two advanced therapies to authorization and... AseBio
AbilityPharma closes €7 million round for metastatic pancreatic cancer drug ABTL0812 11/03/2024 Healthcare Rare diseases Advanced therapies Financing AbilityPharma closes €7 million round to fully fund its international Phase 2b clinical trial with the antitumor drug... Partners - Ability Pharmaceuticals
OneChain Immunotherapeutics has received 1.3M euro grant to advance a new promising CAR T ... 29/02/2024 Healthcare Rare diseases Advanced therapies A consortium led by the Spanish company OneChain Immunotherapeutics has received 1.9M euros from the Spanish Ministry of... Partners - Parc Científic de Barcelona
Why and how to involve rare disease patients in the evaluation process of a new health tec... 27/02/2024 Healthcare Rare diseases Innovative drugs Personalized medicine Advanced therapies Alira Health experts explain in an interview the importance of involving patients with rare diseases in the evaluation... Partners
ORYZON reports financial results and corporate update for quarter ended December 31, 2023 27/02/2024 Healthcare Innovative drugs Personalized medicine Advanced therapies Oryzon Genomics, a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with... Partners - Oryzon Genomics
